3,646 result(s) found
Novo Nordisk (NVO) Is Up 2.45% in One Week: What You Should Know
https://www.zacks.com/stock/news/2210353/novo-nordisk-nvo-is-up-2-45-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2210353
Jan 15, 2024 - Does Novo Nordisk (NVO) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Could AMD Become the Next Nvidia?
https://www.fool.com/investing/2024/01/15/could-amd-become-the-next-nvidia/?source=iedfolrf0000001
Jan 15, 2024 - AMD is gearing up to make a big splash in AI this year.
0
Gear Up for Fifth Third Bancorp (FITB) Q4 Earnings: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2210242/gear-up-for-fifth-third-bancorp-fitb-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2210242
Jan 15, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Fifth Third Bancorp (FITB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
0
Gear Up for Travelers (TRV) Q4 Earnings: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2210240/gear-up-for-travelers-trv-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2210240
Jan 15, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Travelers (TRV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
0
Heartland Mid Cap Value Fund Q4 2023 Portfolio Manager Commentary
https://seekingalpha.com/article/4662697-heartland-mid-cap-value-fund-q4-2023-portfolio-manager-commentary?source=feed_all_articles
Jan 13, 2024 - Heartland Mid Cap Value portfolio was up more than 7.5% in the Q4 2023, trailing the Russell Midcap Value Index. Click here to read the full fund letter.
0
Forget Celsius Holdings: This Stock Has Made Far More Millionaires
https://www.fool.com/investing/2024/01/13/forget-celsius-this-stock-made-more-millionaires/?source=iedfolrf0000001
Jan 13, 2024 - Explore how a recent market sensation stacks up against a seasoned player in the high-stakes game of wealth generation.
0
United Parcel Service (UPS) Stock Falls Amid Market Uptick: What Investors Need to Know
https://www.zacks.com/stock/news/2209764/united-parcel-service-ups-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2209764
Jan 12, 2024 - United Parcel Service (UPS) closed the most recent trading day at $158.31, moving -0.59% from the previous trading session.
0
VivoPower International files for a $18M mixed securities shelf
https://seekingalpha.com/news/4054863-vivopower-international-files-for-a-18m-mixed-securities-shelf?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jan 12, 2024 - VivoPower International files a mixed shelf offering prospectus to raise up to $18M, but it is not an offer to sell securities.
0
Radical Transparency: The Performance Of My 189 Write Ups (April 1, 2020 - January 3, 2024)
https://seekingalpha.com/article/4662588-radical-transparency-the-performance-189-articles?source=feed_tag_etf_portfolio_strategy
Jan 12, 2024 - Discover the success and failures of 189 investment tickers through insightful analysis from 2020-2023, offering key takeaways for financial growth.
0
RBC ups Regeneron to outperform; cites Eylea patent win, Dupi sales
https://seekingalpha.com/news/4054797-rbc-ups-regeneron-to-outperform-cites-eylea-patent-win-dupi-sales?source=feed_sector_healthcare
Jan 12, 2024 - RBC Capital Markets has upgraded Regeneron Pharmaceuticals (REGN) to outperform, citing the company’s R&D pipeline, “strong” Dupi performance and “solid” Eylea
0